Maccura Biotechnology (300463.SZ) has obtained the product registration certificate for its new product.
Maikel Biology (300463.SZ) issued an announcement that the company recently received the "Medical Device... issued by the National Medical Products Administration.
Maccura Biotechnology (300463.SZ) announced that the company recently received the "Medical Device Registration Certificate" (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product name is Pneumonia Mycoplasma IgG Antibody Test Kit (Direct Chemiluminescence Method), which is used for in vitro qualitative detection of Pneumonia Mycoplasma IgG antibodies in human serum or plasma samples.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) transferred the repurchased 13.5111 million A shares to the employee stock ownership plan.

EDIANYUN (02416) spent 528,800 Hong Kong dollars on repurchasing 260,000 shares on November 7th.

Bohai Leasing (000415.SZ) plans to sell 818 million shares of equity in Wanjiang Jinzu to recover investment funds.
Jiangsu Hengrui Pharmaceuticals (01276) transferred the repurchased 13.5111 million A shares to the employee stock ownership plan.

EDIANYUN (02416) spent 528,800 Hong Kong dollars on repurchasing 260,000 shares on November 7th.

Bohai Leasing (000415.SZ) plans to sell 818 million shares of equity in Wanjiang Jinzu to recover investment funds.

RECOMMEND

Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025

Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025

Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025


